REQUEST A DEMO
Total
USD $0.00
Search more companies

Jg Pharm, S.R.O. (Slovakia)

Main Activities: Other Business Support Services
Full name: Jg Pharm, S.R.O. Profile Updated: October 21, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English Download a sample report

Jg Pharm, S.R.O. is based in Slovakia, with the head office in Piestany. The company operates in the Other Business Support Services sector. It was first established on October 17, 2018. 5 - 9 (2023) employees currently work for Jg Pharm, S.R.O.. In 2023, the company reported a net sales revenue increase of 4.79%. There was a total growth of 21.11% in Jg Pharm, S.R.O.’s total assets over the same period. The net profit margin of Jg Pharm, S.R.O. increased by 0.16% in 2023.

Headquarters
Brezova, 2870/12
Piestany; Trnavsky; Postal Code: 92101

Contact Details: Purchase the Jg Pharm, S.R.O. report to view the information.

Basic Information
Total Employees:
Purchase the Jg Pharm, S.R.O. report to view the information.
Outstanding Shares:
Purchase the Jg Pharm, S.R.O. report to view the information.
Registered Capital:
Purchase the Jg Pharm, S.R.O. report to view the information.
Incorporation Date:
October 17, 2018
Key Executives
Purchase this report to view the information.
Legal Representative
Purchase this report to view the information.
Legal Representative
Ownership Details
Purchase this report to view the information.
50%
Purchase this report to view the information.
50%
Company Performance
Financial values in the chart are available after Jg Pharm, S.R.O. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency EUR. Absolute financial data is included in the purchased report.
Net sales revenue
4.79%
Total operating revenue
4.79%
Operating profit (EBIT)
18.24%
EBITDA
2.77%
Net Profit (Loss) for the Period
36.53%
Total assets
21.11%
Total equity
51.22%
Operating Profit Margin (ROS)
0.12%
Net Profit Margin
0.16%
Return on Equity (ROE)
-3.65%
Debt to Equity Ratio
206.27%
Quick Ratio
0.05%
Cash Ratio
-0.03%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?